Other languages Bioretec Oy

Equities

BRETEC

FI4000480454

Market Closed - Nasdaq Helsinki Other stock markets 08:17:33 16/05/2024 pm IST			5-day change	1st Jan Change
2.69 ^EUR	-1.10%		-0.74%	+12.08%

05/04	Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors	CI
22/03	Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors	05/04
Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition	22/03
Bioretec Ltd. Receives a Patent by the U.S. Patent Office for its RemeOs Magnesium Alloy Composition	21/03
Bioretec Secures US FDA Breakthrough Device Designation for Spinal Interbody Cage Implant	14/03
Bioretec Has Been Granted FDA Breakthrough Device Designation Status for its RemeOs Spinal Interbody Cage	14/03
Bioretec Expects EU Regulatory Approval for Trauma Screw in Q2	11/03
Bioretec's European Market Authorization for RemeOs Trauma Screw Proceeded to Expert Panel Evaluation	09/03
Bioretec Ltd Announces CEO Changes	16/11
Bioretec Estimates the Approval of the European Market Authorization for the Biodegradable RemeOs? Trauma Screw Will Move to the First Quarter of 2024	18/23/18
Bioretec Ltd. Enters into the U.S. Distribution Agreement with Spartan Medical Inc. for the RemeOs Screws	12/23/12
Bioretec Ltd Unveils Its Revitalized Scientific Advisory Board	16/23/16
Bioretec Oy Appoints Esa Hallinen as Director of Operations and Member of the Management Team	14/23/14
Bioretec Ltd Acquires New CNC Machining Center to Increase Production Capacity of RemeOs Products at its Factory in Tampere, Finland	13/23/13
Bioretec Oy Approves Management Appointments	26/23/26
Bioretec Ltd Appoints Dr. Jeremy Dublon as Regulatory Advisor	16/23/16
Bioretec Ltd, Receives U.S. Market Authorization for Its RemeOs Trauma Screw from the U.S. Food and Drug Administration	24/23/24
Bioretec Ltd Receives Market Authorization of the U.S. Food and Drug Administration for Its Pioneering Remeos Traversed with the Clinical Trial	30/23/30
Bioretec Ltd Submits Additional Information Requested by the FDA for US Registration of RemeOs Trauma Screws	04/23/04
Bioretec Ltd, Updates Estimate of U.S. registration of RemeOs™ Screws and Expects Approval in April 2023	14/22/14
Bioretec's Hybrid Composite Patent Has Been Approved in Europe	08/22/08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Bioretec Oy

Equities

BRETEC

FI4000480454

Other languages

Filters